Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in ESP Block for PLIF
NCT03746418Phase 1Completed
- Sponsor
- Tanta University
- Start
- Jan 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Tanta University. Primary endpoints: Post-Anesthesia Care Unit length of stay at 24 hours, Total dose of postoperative analgesics need at 24 hours and 2 more. Started Jan 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03746418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03746418.